We also found that patients with RECQL mutations were more likely to have a family history of other tumors, particularly breast cancer (52.00% vs. 37.31%; 38.00% vs. 20.27%), than patients without RECQL mutations. This evidence concerns the gene RECQL and breast carcinoma.